How miR-31-5p and miR-33a-5p Regulates SP1/CX43 Expression in Osteoarthritis Disease: Preliminary Insights
Authors:
- Viviana CostaVCViviana Costa
- Marcello De FineMFMarcello De Fine
- Valeria CarinaVCValeria Carina
- Alice ConigliaroAlice Conigliaro
- Lavinia RaimondiLRLavinia Raimondi
- Angela De LucaALAngela De Luca
- Daniele BellaviaDaniele Bellavia
- Francesca SalamannaFSFrancesca Salamanna
- Riccardo AlessandroRiccardo Alessandro
- Giovanni PignattiGPGiovanni Pignatti
- Milena FiniMilena Fini
- Gianluca GiavaresiGianluca Giavaresi
Open Access
- 28 February 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 22 (5) , 2471
Abstract
Osteoarthritis (OA) is a degenerative bone disease that involved micro and macro-environment of joints. To date, there are no radical curative treatments for OA and novel therapies are mandatory. Recent evidence suggests the role of miRNAs in OA progression. In our previous studies, we demonstrated the role of miR-31-5p and miR-33a families in different bone regeneration signaling. Here, we investigated the role of miR-31-5p and miR-33a-5p in OA progression. A different expression of miR-31-5p and miR-33a-5p into osteoblasts and chondrocytes isolated from joint tissues of OA patients classified in based on different Kellgren and Lawrence (KL) grading was highlighted; and through a bioinformatic approach the common miRNAs target Specificity proteins (Sp1) were identified. Sp1 regulates the expression of gap junction protein Connexin43 (Cx43), which in OA drives the modification of (i) osteoblasts and chondrocytes genes expression, (ii) joint inflammation cytokines releases and (iii) cell functions. Concerning this, thanks to gain and loss of function studies, the possible role of Sp1 as a modulator of CX43 expression through miR-31-5p and miR-33a-5p action was also evaluated. Finally, we hypothesize that both miRNAs cooperate to modulate the expression of SP1 in osteoblasts and chondrocytes and interfering, consequently, with CX43 expression, and they might be further investigated as new possible biomarkers for OA.Keywords
Funding Information
- Fondi 5 per mille ANNO 2017- (Medicina rigenerativa e ricostruttiva per la chirurgia vertebrale: caratterizzazione biologica e strutturale di biomateriali funzionalizzati ed ingegnerizzati”.)
This publication has 37 references indexed in Scilit:
- Inhibition of GSK-3β Rescues the Impairments in Bone Formation and Mechanical Properties Associated with Fracture Healing in Osteoblast Selective Connexin 43 Deficient MicePLOS ONE, 2013
- Human Articular Chondrocytes Express Multiple Gap Junction ProteinsThe American Journal of Pathology, 2013
- Role of Rev‐erbα domains for transactivation of the connexin43 promoter with Sp1FEBS Letters, 2012
- Cell autonomous requirement of connexin 43 for osteocyte survival: Consequences for endocortical resorption and periosteal bone formationJournal of Bone and Mineral Research, 2011
- Plasma and synovial fluid microRNAs as potential biomarkers of rheumatoid arthritis and osteoarthritisArthritis Research & Therapy, 2010
- Sp1/Sp3 and DNA-methylation contribute to basal transcriptional activation of human podoplanin in MG63 versus Saos-2 osteoblastic cellsBMC Molecular Biology, 2007
- Sp1 Family of Transcription Factors Regulates the Human α2 (XI) Collagen Gene (COL11A2) in Saos-2 Osteoblastic CellsJournal of Bone and Mineral Research, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Sp1/Sp3 and PU.1 Differentially Regulate β5Integrin Gene Expression in Macrophages and OsteoblastsJournal of Biological Chemistry, 2000
- Collagen Iα1 Sp1 Polymorphism, Bone Mass, and Bone Turnover in Healthy French Premenopausal Women: The OFELY StudyJournal of Bone and Mineral Research, 1998